Enovis Total Liabilities 2010-2024 | ENOV
Enovis total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Enovis Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $2,154 |
| 2023 | $1,089 |
| 2022 | $823 |
| 2021 | $3,854 |
| 2020 | $3,764 |
| 2019 | $3,897 |
| 2018 | $3,139 |
| 2017 | $2,982 |
| 2016 | $3,245 |
| 2015 | $3,476 |
| 2014 | $3,859 |
| 2013 | $3,860 |
| 2012 | $3,992 |
| 2011 | $899 |
| 2010 | $806 |
| 2009 | $789 |
| Enovis Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $2,154 |
| 2024-09-30 | $2,217 |
| 2024-06-30 | $2,153 |
| 2024-03-31 | $2,168 |
| 2023-12-31 | $1,089 |
| 2023-09-30 | $959 |
| 2023-06-30 | $993 |
| 2023-03-31 | $854 |
| 2022-12-31 | $823 |
| 2022-09-30 | $1,037 |
| 2022-06-30 | $1,012 |
| 2022-03-31 | $3,840 |
| 2021-12-31 | $3,854 |
| 2021-09-30 | $3,342 |
| 2021-06-30 | $3,208 |
| 2021-03-31 | $3,776 |
| 2020-12-31 | $3,764 |
| 2020-09-30 | $3,697 |
| 2020-06-30 | $3,727 |
| 2020-03-31 | $4,118 |
| 2019-12-31 | $3,897 |
| 2019-09-30 | $6,458 |
| 2019-06-30 | $6,643 |
| 2019-03-31 | $6,761 |
| 2018-12-31 | $3,139 |
| 2018-09-30 | $2,968 |
| 2018-06-30 | $2,925 |
| 2018-03-31 | $3,038 |
| 2017-12-31 | $2,982 |
| 2017-09-30 | $3,325 |
| 2017-06-30 | $3,358 |
| 2017-03-31 | $3,218 |
| 2016-12-31 | $3,245 |
| 2016-09-30 | $3,374 |
| 2016-06-30 | $3,418 |
| 2016-03-31 | $3,485 |
| 2015-12-31 | $3,476 |
| 2015-09-30 | $3,736 |
| 2015-06-30 | $3,581 |
| 2015-03-31 | $3,697 |
| 2014-12-31 | $3,859 |
| 2014-09-30 | $3,992 |
| 2014-06-30 | $4,278 |
| 2014-03-31 | $3,375 |
| 2013-12-31 | $3,860 |
| 2013-09-30 | $3,764 |
| 2013-06-30 | $3,690 |
| 2013-03-31 | $3,782 |
| 2012-12-31 | $3,992 |
| 2012-09-30 | $3,876 |
| 2012-06-30 | $3,901 |
| 2012-03-31 | $3,910 |
| 2011-12-31 | $899 |
| 2011-09-30 | $793 |
| 2011-06-30 | $809 |
| 2011-03-31 | $825 |
| 2010-12-31 | $806 |
| 2010-09-30 | $778 |
| 2010-06-30 | $781 |
| 2010-03-31 | $796 |
| 2009-12-31 | $789 |
| 2009-09-30 | $829 |
| 2009-06-30 | $717 |
| 2009-03-31 | $721 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.825B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Veradigm (MDRX) | United States | $0.449B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |